Dr. Evans is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
4401 Harrison Blvd
Ogden, UT 84403Phone+1 801-387-7484
Summary
- I am a Radiation Oncologist practicing at the Intermountain Cancer Centers at McKay-Dee and Logan Regional Hospitals in Utah. I strive to provide the best and most advanced forms of radiation services to my patients. I received world-class, comprehensive training in radiation oncology at the Mayo Clinic in Rochester, MN. My expertise includes HDR and LDR brachytherapy procedures for prostate, breast, gastrointestinal, and gynecologic malignancies. In addition to brachytherapy and conventional forms of external beam radiotherapy, I have experience in applications of stereotactic radiotherapy including: Gamma Knife SRS, LINAC-based SRS and SBRT of the brain, spine, liver, lung, prostate, oligometastatic osseous and soft tissue sites.
Research and patient education are critical components of my practice. Helping my patients understand their disease in order to heal is an important part of the cancer care journey. My primary research focus is in understanding how radiotherapy and immunotherapy (i.e. treatment that turns patients' immune system on against their cancer) can be used together to improve clinical outcomes. I direct the Radiation Immunology and Precision Radiotherapy research program at Intermountain Healthcare, which is a collaborative program aimed at developing next-generation Immuno-Radiotherapeutic treatment strategies.
Above all, I practice the primary value of my Mayo Clinic training, “the needs of the patient come first”. High-quality, patient-centered care is very important to me as a radiation oncologist. I believe research elevates my clinical practice and my patients, through their experience and outcomes, educate me on where the science needs to go. I’m optimistic about the future of oncology and I'm thrilled to be a part of the Intermountain team. Working as a multidisciplinary team and coordinating care in order to deliver exceptional results for each and every one of my patients is my top professional priority.
Education & Training
- Mayo Clinic College of Medicine and Science (Rochester)Residency, Radiation Oncology, 2014 - 2019
- Intermountain Medical CenterInternship, Transitional Year, 2014 - 2015
- Texas Tech University Health Sciences Center School of MedicineClass of 2014, MD, Alpha Omega Alpha Honor Medical Society, Gold Humanism Honor Society
- Brigham Young UniversityBS, Biology, Valedictorian and College of Life Sciences Convocation Speaker, 2007 - 2010
Certifications & Licensure
- UT State Medical License 2019 - 2026
- MN State Medical License 2015 - 2019
- American Board of Radiology Radiation Oncology
Clinical Trials
- Study of Proton SBRT and Immunotherapy for Recurrent/Progressive Locoregional or Metastatic Head and Neck Cancer Start of enrollment: 2018 Jul 03
Publications & Presentations
PubMed
- 126 citationsProstate cancer-specific PET radiotracers: A review on the clinical utility in recurrent disease.Jaden D. Evans, Krishan R. Jethwa, Piet Ost, Scott Williams, Eugene D. Kwon
Practical Radiation Oncology. 2018-01-01 - 18 citationsProspective Immunophenotyping of CD8+ T Cells and Associated Clinical Outcomes of Patients With Oligometastatic Prostate Cancer Treated With Metastasis-Directed SBRT.Jaden D. Evans, Lindsay Kaye Morris, Henan Zhang, Siyu Cao, Xin Liu
International Journal of Radiation Oncology, Biology, Physics. 2019-01-01 - 23 citationsAppendicitis risk prediction models in children presenting with right iliac fossa pain (RIFT study): a prospective, multicentre validation studyD Nepogodiev, Richard Wilkin, Catherine J Bradshaw, Clare Skerritt, Alasdair Ball
The Lancet. Child & Adolescent Health. 2020-04-01
Journal Articles
- 11C-Choline PET-guided salvage radiotherapy for isolated pelvic and para-aortic nodal recurrence of prostate cancer after radical prostatectomy: rationale and early ge...Jethwa KR, Hellekson CD, Evans JD, et al, Adv Radiat Oncol, 7/2019
- Prospective Immunophenotyping of CD8+ T Cells and Associated Clinical Outcomes of Patients With Oligometastatic Prostate Cancer Treated With Metastasis-Directed SBRTEvans JD, Morris LK, Zhang H, Cao S, Liu X, Mara KC, Stish BJ, Davis BJ, Mansfield AS, Dronca RS, Iott MJ, Kwon ED, Foote RL, Olivier KR, Dong H, Park SS., Int J Radiat Oncol Biol Phys, 1/1/2019
- A Prospective Pilot Study of Single 19 Gy Fraction High-Dose-Rate Brachytherapy for Favorable-Risk Adenocarcinoma of the ProstateDahlbeck, S, Hansen, CC, deRiese, W, Kagan, AR, Torres, C, Chiriva-Internati, M, Cobos, E, Figueroa, JA, Nguyen, D, Tijani, L, and Evans JD., J Nucl Med Radiat Ther, 3/9/2015
Books/Book Chapters
Other
- Compositions and Methods for Cancer Management using Antibodies Binding to Nucleotide Salvage Pathway Enzymes and Complexes Thereof.O'Neill KL, Whitehurst R, Evans JD, Sharp D, Allegre M., United States Patent Office
http://appft1.uspto.gov/netacgi/nph-Parser?Sect1=PTO1&Sect2=HITOFF&d=PG01&p=1&u=/netahtml/PTO/srchnum.html&r=1&f=G&l=50&s1=20110176996.PGNR.&OS=DN/20110176996&RS=DN/20110176996
United States Patents - 7/21/2011
Press Mentions
- Mayo Clinic Physicians Present Research Findings at 2016 ASTRO Annual MeetingSeptember 23rd, 2016
Committees
- Associate Member, Mayo Clinic Cancer Center Data Safety Monitoring Board 2017 - 2019
- Member, Mayo Clinic Education Committee - Department of Radiation Oncology 2015 - 2019
Professional Memberships
- Member
- Member
- American Society for Radiation Oncology - ASTROMember
Other Languages
- Spanish
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: